Developer docs
API playgroundTry for free, no card

Search company profiles

Lung Cancer Research Foundation

Full company profile

uuid000s6i7

Namestring
Lung Cancer Research Foundation
Legal namestring
Lung Cancer Research Foundation
Company typeenum
Private
Founded yearint
2000
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
lung cancer research funding, nonprofit health advocacy, cancer research grants, patient support services, medical education materials
Industry2 codes
1Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS)
CodeBPAGACAAPrimaryYes
2Health & Medical Research Grantmaking Foundations
CodeBPAGAKALPrimaryNo
NAICS code2 codes
  • Voluntary Health Organizations813212
  • Grantmaking Foundations813211
SIC code1 code
  • Services-Health Services8000
Product category
Cancer Research Nonprofit
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model10 records
1Individual Donations
TypeGrants Donations
Description

Direct charitable contributions from individuals supporting lung cancer research

lungcancerresearchfoundation.org
2Memorial and Honor Gifts
TypeGrants Donations
Description

Gifts made in honor or memory of loved ones, including In Memory Wall plaque purchases at $500, $1,000, and $5,000+ levels

lungcancerresearchfoundation.org
3Bequests and Planned Giving
TypeGrants Donations
Description

Will bequests, trusts, life insurance, retirement plans facilitated through FreeWill partnership

lungcancerresearchfoundation.org
4IRA Charitable Distributions
TypeGrants Donations
Description

Qualified charitable distributions from IRAs for donors 70.5+ years old

lungcancerresearchfoundation.org
5Donor-Advised Funds
TypeGrants Donations
Description

Grants from DAFs with automated linking for convenience

lungcancerresearchfoundation.org
6Securities and Stock Donations
TypeGrants Donations
Description

Appreciated stock donations avoiding capital gains tax

lungcancerresearchfoundation.org
7Cryptocurrency Donations
TypeGrants Donations
Description

Accepts Ethereum, Bitcoin, and other cryptocurrencies

lungcancerresearchfoundation.org
8Workplace Giving
TypeGrants Donations
Description

Payroll deduction programs and Combined Federal Campaign (CFC #42372) for federal employees

lungcancerresearchfoundation.org
9Corporate Partnerships and Sponsorship
TypeGrants Donations
Description

Pharmaceutical and healthcare company sponsorships for events, programs, and educational materials

lungcancerresearchfoundation.org
10Event Revenue
TypeGrants Donations
Description

Registration fees and fundraising from walks, galas, and endurance race teams

lungcancerresearchfoundation.org
Marketing channels11 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels7 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Core offering1 text field

Lung Cancer Research Foundation (LCRF) is a 501(c)(3) nonprofit that funds innovative lung cancer research through competitive grant programs (450 grants totaling nearly $53 million) and delivers patient and caregiver support services including a toll-free Lung Cancer Support Line, free educational materials on biomarker testing, clinical trials and immunotherapy, clinical trial matching via Carebox, and Together Separately educational livestreams. The organization also operates community fundraising events such as Free to Breathe Walks, Team LCRF endurance teams, and an annual Gala and Scientific Symposium.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 87 cents of every dollar goes directly to funding mission-related programs and services
+2 more records
Product overview1 text field

Lung Cancer Research Foundation (LCRF) is a nonprofit organization focused on funding innovative lung cancer research and supporting patients and caregivers. The organization operates a multi-pronged service model consisting of: (1) Patient support services including a toll-free Lung Cancer Support Line staffed by a licensed clinical social worker with interpretation in 200+ languages; (2) Free educational programs including Together Separately Livestreams featuring expert discussions on treatment advances; (3) Patient/caregiver educational materials covering biomarker testing, clinical trials, immunotherapy, and living with lung cancer available in English and Spanish; (4) Fundraising events including Free to Breathe Walks (Kansas City, Chicago, Anywhere), Team LCRF endurance events, and Free to Breathe Your Way individual fundraisers; (5) Clinical trial matching through Carebox partnership; (6) Continuing education for medical professionals through Medlive Cancer; (7) Planned giving programs through FreeWill partnership; and (8) Community awareness initiatives including Know Your Risk programs for underserved populations.

Product and service15 records
1Lung Cancer Support Line
CategoryPatient Support Service
Description

Toll-free support line (844-835-4325) staffed by a licensed clinical social worker, available Monday-Friday 9am-5pm ET, providing personalized resource navigation, financial assistance referrals, transportation and lodging help, clinical trial guidance, and peer connections for lung cancer patients and caregivers, with interpretation in 200+ languages.

2Patient Educational Materials
CategoryEducational Resources
Description

Free printed and digital educational booklets covering Living with Lung Cancer, Biomarker Testing, Clinical Trials, Immunotherapy, and caregiving. Available in English and Spanish with free shipping within the U.S., designed for patients and caregivers.

3Clinical Trial Matching (via Carebox)
CategoryPatient Support Service
Description

Partnership service that lets patients, caregivers, and healthcare professionals search and match to lung cancer clinical trials through a short questionnaire covering diagnosis, stage, and treatment history.

4Free to Breathe Walk
CategoryFundraising Events
Description

Community walk events including the Kansas City Walk, Chicago Walk, and Anywhere Walk that bring supporters together to raise awareness and funds for lung cancer research.

5Free to Breathe Your Way
CategoryFundraising Programs
Description

Individual/community fundraising program enabling supporters to turn any activity (golfing, bowling, baking, music, yoga, parties) into a personal fundraiser for lung cancer research.

6Team LCRF Endurance Events
CategoryFundraising Programs
Description

Charity partnership program for endurance races including TCS New York City Marathon, United Airlines NYC Half, and Five Boro Bike Tour, letting participants meet fitness goals while fundraising for lung cancer research.

7Together Separately Livestreams
CategoryEducational Programs
Description

Educational webinar series featuring expert moderators and guest speakers discussing lung cancer treatment navigation, the latest research findings, and conference recaps from ASCO and WCLC, with a companion Facebook community group.

8Comprehensive Biomarker Testing Education
CategoryEducational Resources
Description

Educational resource covering biomarker testing, oncogenic driver mutations, immunotherapy biomarkers, and targeted therapies for NSCLC treatment, including information on KRAS, EGFR, ALK, and other mutations with FDA-approved treatment options.

9Patient and Caregiver Kit
CategoryPatient Support Materials
Description

Complimentary tote bag filled with supportive items and resources for patients and caregivers on their lung cancer journey, distributed free of charge.

10Healthcare Provider Kit
CategoryHealthcare Provider Resources
Description

Kit containing one copy of each LCRF resource, enabling healthcare providers to evaluate which LCRF materials best suit the needs of their lung cancer patients for clinic distribution.

11Planned Giving and Legacy Programs
CategoryDonor Programs
Description

Gift planning services including bequests, IRA charitable distributions, Donor-Advised Fund grants, gifts of appreciated securities, and cryptocurrency donations, facilitated through the FreeWill partnership.

12Continuing Education for Medical Professionals
CategoryProfessional Education
Description

Free online continuing education opportunities for oncologists, pulmonologists, nurses, and other medical professionals treating lung cancer, offered through partnership with Medlive Cancer.

13Know Your Risk Program
CategoryCommunity Awareness Program
Description

Awareness initiative increasing understanding of lung cancer risk in Black and Hispanic American populations through culturally tailored educational resources and outreach materials.

14In Memory Wall
CategoryMemorial Program
Description

Online virtual memorial wall honoring lives lost to lung cancer, offering digital plaques at $500, $1,000, and $5,000+ giving levels as memorial tributes.

15LCRF Scientific Symposium
CategoryScientific Events
Description

Annual scientific symposium held during Lung Cancer Awareness Month featuring State of the Science updates, emerging research presentations, and the Lung Cancer Mutation Consortium.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership25 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Pharmaceutical research partner supporting LCRF's mission to fund innovative lung cancer research. AstraZeneca is one of LCRF's key corporate research partners providing funding for research grants and programs.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Pharmaceutical research partner and sponsor of LCRF events including Free to Breathe walks and Together Separately livestreams. Supports lung cancer research funding and patient education programs.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Corporate research partner and event sponsor, supporting LCRF's Free to Breathe events and Women and Lung Cancer Program. Provides funding for research initiatives and patient resources.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Molecular information company providing biomarker testing support. Sponsor of educational materials on comprehensive biomarker testing for lung cancer, helping patients access tumor testing.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Major pharmaceutical sponsor supporting LCRF programs including the Lung Cancer Support Line (funding interpretation services), Free to Breathe events, and Women and Lung Cancer Program.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Presenting sponsor for Free to Breathe national events, supporting lung cancer awareness walks and fundraising initiatives across the country.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

National sponsor for Free to Breathe events and supporter of Healthcare Provider Kits through Johnson & Johnson Foundation funding.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Pharmaceutical sponsor supporting Free to Breathe events and biomarker testing educational materials, advancing lung cancer research awareness.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Presenting sponsor for Free to Breathe Chicago Walk and sponsor of Together Separately livestreams, supporting patient education and community engagement.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partner providing free online continuing education opportunities for medical professionals in partnership with LCRF.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Clinical trial matching partnership allowing LCRF to provide patients with easy search and match to lung cancer clinical trials through a short questionnaire.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnership providing lung cancer patients and caregivers with trained volunteer survivors for peer support and connection.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Sponsor of LCRF's Lung Cancer Support Line, helping fund free support services for patients and caregivers.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Sponsor of LCRF's Lung Cancer Support Line supporting free patient support services.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Sponsor of LCRF's Lung Cancer Support Line and educational materials on biomarker testing.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Sponsor of Together Separately livestream webinar series providing educational content to lung cancer community.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Sponsor of Together Separately livestream educational series on lung cancer research and treatment.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Co-presenter of special edition Together Separately livestream on heritable genetics in lung cancer, in partnership with LCRF and other organizations.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Sponsor of Together Separately livestream educational series on lung cancer.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Online gift planning partner providing free will-planning resource for donors to include LCRF in their estate planning.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Design marketplace charity partner where purchases using code FUNDRAISELCRF donate 10% of purchase price to LCRF and provide 20% discount to supporters.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research partner supporting lung cancer research initiatives and professional education in the lung cancer field.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Sponsor of Healthcare Provider Kits and biomarker testing educational materials including the Lilly Lung Cancer NGS Program for no-cost comprehensive biomarker testing.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Sponsor of educational materials on biomarker testing for lung cancer.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Sponsor of educational materials on biomarker testing for lung cancer.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Disease-specific (all-cancer) research grantmaking nonprofit with a similar high-impact, translational-research funding model. Competes for major-donor and corporate-sponsored cancer research dollars.

TypeOthers
Description

While focused on breast cancer rather than lung cancer, Komen serves as the gold-standard disease-specific research nonprofit model — analogous structure (research grants + patient support + walks + corporate sponsorships + transparency ratings) that defines the competitive fundraising landscape LCRF operates within.

TypeDirect peer
Description

Cancer-specific research and education nonprofit with a comparable mix of research grants, public awareness campaigns, and patient education programs. Operates at a similar scale and competes in the same federal-employee CFC workplace-giving space.

TypeDirect peer
Description

Direct peer focused specifically on lung cancer research funding, patient education, and survivorship programs. Competes head-to-head with LCRF for research grant applications, donor dollars, and corporate research sponsorships.

TypeDirect peer
Description

High-profile collaborative cancer research funder using a similar translational-research grant model. Competes for corporate sponsorships (pharma, media partners) and celebrity-driven fundraising attention.

TypeBroad incumbent
Description

A larger, established nonprofit covering all lung diseases (not just cancer). Funds lung cancer research alongside COPD, asthma, and tobacco control, with much broader brand recognition and a deeper corporate-giving infrastructure that overlaps LCRF's donor pool.

TypeDirect peer
Description

Cancer-specific research grantmaking nonprofit with a similar donor-funded translational-research model, including planned-giving, memorial giving, and international research collaborations.

TypeBroad incumbent
Description

The largest U.S. cancer nonprofit, funding research across all cancer types including lung cancer. Operates a national research grants program that competes directly with LCRF for investigator applications and major-donor philanthropy.

TypeEmerging player
Description

Smaller, disease-specific research nonprofit focused on mesothelioma, a lung-related cancer. Overlaps with LCRF in research funding approach, biomarker/clinical trial education, and patient advocacy niche.

TypeDirect peer
Description

The closest direct peer: also a U.S. nonprofit dedicated to lung cancer, combining research funding, patient support, and advocacy. Formed from the merger of the Bonnie J. Addario Lung Cancer Foundation and the Lung Cancer Alliance, competing for the same donors, sponsors, and researchers as LCRF.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile6 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration6 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Lung Cancer Research Foundation

Cancer Research Nonprofitlungcancerresearchfoundation.org

Lung Cancer Research Foundation firmographics

Firmographics
Name
Lung Cancer Research Foundation
Legal name
Lung Cancer Research Foundation
Website
https://lungcancerresearchfoundation.org
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Lung Cancer Research Foundation industry classification

Industry
Product category
Cancer Research Nonprofit
NAICS
Voluntary Health Organizations (813212), Grantmaking Foundations (813211)
SIC
Services-Health Services (8000)
akta.pro primary industry
Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)
akta.pro secondary industry
Health & Medical Research Grantmaking Foundations (BPAGAKAL)

Keywords

  • Lung cancer research funding
  • Nonprofit health advocacy
  • Cancer research grants
  • Patient support services
  • Medical education materials

Where Lung Cancer Research Foundation is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Lung Cancer Research Foundation business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Individual Donations: Direct charitable contributions from individuals supporting lung cancer research
  2. Memorial and Honor Gifts: Gifts made in honor or memory of loved ones, including In Memory Wall plaque purchases at $500, $1,000, and $5,000+ levels
  3. Bequests and Planned Giving: Will bequests, trusts, life insurance, retirement plans facilitated through FreeWill partnership
  4. IRA Charitable Distributions: Qualified charitable distributions from IRAs for donors 70.5+ years old
  5. Donor-Advised Funds: Grants from DAFs with automated linking for convenience
  6. Securities and Stock Donations: Appreciated stock donations avoiding capital gains tax
  7. Cryptocurrency Donations: Accepts Ethereum, Bitcoin, and other cryptocurrencies
  8. Workplace Giving: Payroll deduction programs and Combined Federal Campaign (CFC #42372) for federal employees
  9. Corporate Partnerships and Sponsorship: Pharmaceutical and healthcare company sponsorships for events, programs, and educational materials
  10. Event Revenue: Registration fees and fundraising from walks, galas, and endurance race teams

Go-to-market motion1 record

Distribution channels7 records

Marketing channels11 records

Lung Cancer Research Foundation product offering

Product offering

Core offering

Lung Cancer Research Foundation (LCRF) is a 501(c)(3) nonprofit that funds innovative lung cancer research through competitive grant programs (450 grants totaling nearly $53 million) and delivers patient and caregiver support services including a toll-free Lung Cancer Support Line, free educational materials on biomarker testing, clinical trials and immunotherapy, clinical trial matching via Carebox, and Together Separately educational livestreams. The organization also operates community fundraising events such as Free to Breathe Walks, Team LCRF endurance teams, and an annual Gala and Scientific Symposium.

Product overview

Lung Cancer Research Foundation (LCRF) is a nonprofit organization focused on funding innovative lung cancer research and supporting patients and caregivers. The organization operates a multi-pronged service model consisting of: (1) Patient support services including a toll-free Lung Cancer Support Line staffed by a licensed clinical social worker with interpretation in 200+ languages; (2) Free educational programs including Together Separately Livestreams featuring expert discussions on treatment advances; (3) Patient/caregiver educational materials covering biomarker testing, clinical trials, immunotherapy, and living with lung cancer available in English and Spanish; (4) Fundraising events including Free to Breathe Walks (Kansas City, Chicago, Anywhere), Team LCRF endurance events, and Free to Breathe Your Way individual fundraisers; (5) Clinical trial matching through Carebox partnership; (6) Continuing education for medical professionals through Medlive Cancer; (7) Planned giving programs through FreeWill partnership; and (8) Community awareness initiatives including Know Your Risk programs for underserved populations.

Differentiator

Problem solved

Functional benefit

Products and services

  • Lung Cancer Support Line Toll-free support line (844-835-4325) staffed by a licensed clinical social worker, available Monday-Friday 9am-5pm ET, providing personalized resource navigation, financial assistance referrals, transportation and lodging help, clinical trial guidance, and peer connections for lung cancer patients and caregivers, with interpretation in 200+ languages.
  • Patient Educational Materials Free printed and digital educational booklets covering Living with Lung Cancer, Biomarker Testing, Clinical Trials, Immunotherapy, and caregiving. Available in English and Spanish with free shipping within the U.S., designed for patients and caregivers.
  • Clinical Trial Matching (via Carebox) Partnership service that lets patients, caregivers, and healthcare professionals search and match to lung cancer clinical trials through a short questionnaire covering diagnosis, stage, and treatment history.
  • Free to Breathe Walk Community walk events including the Kansas City Walk, Chicago Walk, and Anywhere Walk that bring supporters together to raise awareness and funds for lung cancer research.
  • Free to Breathe Your Way Individual/community fundraising program enabling supporters to turn any activity (golfing, bowling, baking, music, yoga, parties) into a personal fundraiser for lung cancer research.
  • Team LCRF Endurance Events Charity partnership program for endurance races including TCS New York City Marathon, United Airlines NYC Half, and Five Boro Bike Tour, letting participants meet fitness goals while fundraising for lung cancer research.
  • Together Separately Livestreams Educational webinar series featuring expert moderators and guest speakers discussing lung cancer treatment navigation, the latest research findings, and conference recaps from ASCO and WCLC, with a companion Facebook community group.
  • Comprehensive Biomarker Testing Education Educational resource covering biomarker testing, oncogenic driver mutations, immunotherapy biomarkers, and targeted therapies for NSCLC treatment, including information on KRAS, EGFR, ALK, and other mutations with FDA-approved treatment options.
  • Patient and Caregiver Kit Complimentary tote bag filled with supportive items and resources for patients and caregivers on their lung cancer journey, distributed free of charge.
  • Healthcare Provider Kit Kit containing one copy of each LCRF resource, enabling healthcare providers to evaluate which LCRF materials best suit the needs of their lung cancer patients for clinic distribution.
  • Planned Giving and Legacy Programs Gift planning services including bequests, IRA charitable distributions, Donor-Advised Fund grants, gifts of appreciated securities, and cryptocurrency donations, facilitated through the FreeWill partnership.
  • Continuing Education for Medical Professionals Free online continuing education opportunities for oncologists, pulmonologists, nurses, and other medical professionals treating lung cancer, offered through partnership with Medlive Cancer.
  • Know Your Risk Program Awareness initiative increasing understanding of lung cancer risk in Black and Hispanic American populations through culturally tailored educational resources and outreach materials.
  • In Memory Wall Online virtual memorial wall honoring lives lost to lung cancer, offering digital plaques at $500, $1,000, and $5,000+ giving levels as memorial tributes.
  • LCRF Scientific Symposium Annual scientific symposium held during Lung Cancer Awareness Month featuring State of the Science updates, emerging research presentations, and the Lung Cancer Mutation Consortium.

Quantifiable outcome

  • 87 cents of every dollar goes directly to funding mission-related programs and services
  • +2 more outcomes

Companies that use Lung Cancer Research Foundation

Customer profile

Named customers5 records

Segments5 records

Ideal customer profiles6 records

Lung Cancer Research Foundation technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration6 records

Lung Cancer Research Foundation partnerships and signals

Strategic signal

Partnerships

25 partnerships are on record, tiered core and minor.

  • AstraZenecacoreStrategic or Co-development PartnerPharmaceutical research partner supporting LCRF's mission to fund innovative lung cancer research. AstraZeneca is one of LCRF's key corporate research partners providing funding for research grants and programs.
  • Boehringer IngelheimcoreStrategic or Co-development PartnerPharmaceutical research partner and sponsor of LCRF events including Free to Breathe walks and Together Separately livestreams. Supports lung cancer research funding and patient education programs.
  • BayercoreStrategic or Co-development PartnerCorporate research partner and event sponsor, supporting LCRF's Free to Breathe events and Women and Lung Cancer Program. Provides funding for research initiatives and patient resources.
  • Foundation MedicinecoreStrategic or Co-development PartnerMolecular information company providing biomarker testing support. Sponsor of educational materials on comprehensive biomarker testing for lung cancer, helping patients access tumor testing.
  • Merck & Co., Inc.coreStrategic or Co-development PartnerMajor pharmaceutical sponsor supporting LCRF programs including the Lung Cancer Support Line (funding interpretation services), Free to Breathe events, and Women and Lung Cancer Program.
  • Pfizer OncologycoreStrategic or Co-development PartnerPresenting sponsor for Free to Breathe national events, supporting lung cancer awareness walks and fundraising initiatives across the country.
  • Johnson & JohnsoncoreStrategic or Co-development PartnerNational sponsor for Free to Breathe events and supporter of Healthcare Provider Kits through Johnson & Johnson Foundation funding.
  • Summit TherapeuticscoreStrategic or Co-development PartnerPharmaceutical sponsor supporting Free to Breathe events and biomarker testing educational materials, advancing lung cancer research awareness.
  • AbbViecoreStrategic or Co-development PartnerPresenting sponsor for Free to Breathe Chicago Walk and sponsor of Together Separately livestreams, supporting patient education and community engagement.
  • Medlive CancerminorStrategic or Co-development PartnerPartner providing free online continuing education opportunities for medical professionals in partnership with LCRF.
  • CareboxminorStrategic or Co-development PartnerClinical trial matching partnership allowing LCRF to provide patients with easy search and match to lung cancer clinical trials through a short questionnaire.
  • Cancer Hope NetworkminorStrategic or Co-development PartnerPartnership providing lung cancer patients and caregivers with trained volunteer survivors for peer support and connection.
  • BioNTechminorStrategic or Co-development PartnerSponsor of LCRF's Lung Cancer Support Line, helping fund free support services for patients and caregivers.
  • NuvalentminorStrategic or Co-development PartnerSponsor of LCRF's Lung Cancer Support Line supporting free patient support services.
  • Taiho OncologyminorStrategic or Co-development PartnerSponsor of LCRF's Lung Cancer Support Line and educational materials on biomarker testing.
  • RegeneronminorGTM or Marketing PartnerSponsor of Together Separately livestream webinar series providing educational content to lung cancer community.
  • Bristol Myers SquibbminorGTM or Marketing PartnerSponsor of Together Separately livestream educational series on lung cancer research and treatment.
  • Susan Wojcicki FoundationminorGTM or Marketing PartnerCo-presenter of special edition Together Separately livestream on heritable genetics in lung cancer, in partnership with LCRF and other organizations.
  • GenentechminorGTM or Marketing PartnerSponsor of Together Separately livestream educational series on lung cancer.
  • FreeWillminorGTM or Marketing PartnerOnline gift planning partner providing free will-planning resource for donors to include LCRF in their estate planning.
  • MintedminorGTM or Marketing PartnerDesign marketplace charity partner where purchases using code FUNDRAISELCRF donate 10% of purchase price to LCRF and provide 20% discount to supporters.
  • International Association for the Study of Lung Cancer (IASLC)coreStrategic or Co-development PartnerResearch partner supporting lung cancer research initiatives and professional education in the lung cancer field.
  • Eli Lilly and CompanycoreStrategic or Co-development PartnerSponsor of Healthcare Provider Kits and biomarker testing educational materials including the Lilly Lung Cancer NGS Program for no-cost comprehensive biomarker testing.
  • GileadminorStrategic or Co-development PartnerSponsor of educational materials on biomarker testing for lung cancer.
  • Takeda OncologyminorStrategic or Co-development PartnerSponsor of educational materials on biomarker testing for lung cancer.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Lung Cancer Research Foundation competitors and assessment

Company assessment

Direct peers

  • V Foundation for Cancer Research: Disease-specific (all-cancer) research grantmaking nonprofit with a similar high-impact, translational-research funding model. Competes for major-donor and corporate-sponsored cancer research dollars.
  • Prevent Cancer Foundation: Cancer-specific research and education nonprofit with a comparable mix of research grants, public awareness campaigns, and patient education programs. Operates at a similar scale and competes in the same federal-employee CFC workplace-giving space.
  • LUNGevity Foundation: Direct peer focused specifically on lung cancer research funding, patient education, and survivorship programs. Competes head-to-head with LCRF for research grant applications, donor dollars, and corporate research sponsorships.
  • Stand Up To Cancer: High-profile collaborative cancer research funder using a similar translational-research grant model. Competes for corporate sponsorships (pharma, media partners) and celebrity-driven fundraising attention.
  • National Foundation for Cancer Research: Cancer-specific research grantmaking nonprofit with a similar donor-funded translational-research model, including planned-giving, memorial giving, and international research collaborations.
  • GO2 Foundation for Lung Cancer: The closest direct peer: also a U.S. nonprofit dedicated to lung cancer, combining research funding, patient support, and advocacy. Formed from the merger of the Bonnie J. Addario Lung Cancer Foundation and the Lung Cancer Alliance, competing for the same donors, sponsors, and researchers as LCRF.

Others

  • Susan G. Komen: While focused on breast cancer rather than lung cancer, Komen serves as the gold-standard disease-specific research nonprofit model — analogous structure (research grants + patient support + walks + corporate sponsorships + transparency ratings) that defines the competitive fundraising landscape LCRF operates within.

Broad incumbents

  • American Lung Association: A larger, established nonprofit covering all lung diseases (not just cancer). Funds lung cancer research alongside COPD, asthma, and tobacco control, with much broader brand recognition and a deeper corporate-giving infrastructure that overlaps LCRF's donor pool.
  • American Cancer Society: The largest U.S. cancer nonprofit, funding research across all cancer types including lung cancer. Operates a national research grants program that competes directly with LCRF for investigator applications and major-donor philanthropy.

Emerging players

  • Mesothelioma Applied Research Foundation: Smaller, disease-specific research nonprofit focused on mesothelioma, a lung-related cancer. Overlaps with LCRF in research funding approach, biomarker/clinical trial education, and patient advocacy niche.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Lung Cancer Research Foundation social profiles

Digital presence

Lung Cancer Research Foundation compliance and trust

Trust signal

Compliance3 records

Lung Cancer Research Foundation financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Lung Cancer Research Foundation leadership team

Management profile

Number of profiles

Profiles8 records

Lung Cancer Research Foundation funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Lung Cancer Research Foundation M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lung Cancer Research Foundation

What does Lung Cancer Research Foundation do?

Lung Cancer Research Foundation (LCRF) is a 501(c)(3) nonprofit that funds innovative lung cancer research through competitive grant programs (450 grants totaling nearly $53 million) and delivers patient and caregiver support services including a toll-free Lung Cancer Support Line, free educational materials on biomarker testing, clinical trials and immunotherapy, clinical trial matching via Carebox, and Together Separately educational livestreams. The organization also operates community fundraising events such as Free to Breathe Walks, Team LCRF endurance teams, and an annual Gala and Scientific Symposium.

Is Lung Cancer Research Foundation a public or private company?

Lung Cancer Research Foundation is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Lung Cancer Research Foundation founded?

Lung Cancer Research Foundation was founded in 2000. It employs 11 to 50 people.

Where is Lung Cancer Research Foundation based?

Lung Cancer Research Foundation is headquartered in New York, United States, in the North America region.

How does Lung Cancer Research Foundation make money?

Ten revenue lines are on record. Individual Donations are the primary driver. The others are memorial and Honor Gifts, bequests and Planned Giving, IRA Charitable Distributions, donor-Advised Funds, securities and Stock Donations, cryptocurrency Donations, workplace Giving, corporate Partnerships and Sponsorship and event Revenue.

Who are Lung Cancer Research Foundation's main competitors?

Direct peers on record are V Foundation for Cancer Research, Prevent Cancer Foundation, LUNGevity Foundation, Stand Up To Cancer, National Foundation for Cancer Research and GO2 Foundation for Lung Cancer. Susan G. Komen is listed as an others. Broad incumbents are American Lung Association and American Cancer Society. Mesothelioma Applied Research Foundation is listed as an emerging player.

Does Lung Cancer Research Foundation have an API?

No public API is recorded for Lung Cancer Research Foundation.

What industry is Lung Cancer Research Foundation in?

Lung Cancer Research Foundation's product category is Cancer Research Nonprofit. Its primary akta.pro industry code is BPAGACAA, Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS), with a secondary code of BPAGAKAL, Health & Medical Research Grantmaking Foundations. Its NAICS code is 813212 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireInaugural 'Here Comes Summer' Benefit Fuels Lung Cancer Research, Honors Legacy of Donna SummerThe Lung Cancer Research Foundation hosted its inaugural 'Here Comes Summer' benefit in Nashville on June 9, 2026, raising $185,000 to date for lung cancer research while honoring the legacy of legendary entertainer Donna Summer, who died from lung cancer in 2012. The sold-out event at Richland Country Club brought together members of the Nashville music, healthcare, and business communities, cancer researchers, clinicians, and patients, featuring remarks from lung cancer experts and patient advocates. Dr. David Spigel of Sarah Cannon Research Institute highlighted progress in lung cancer treatment over the past 23 years, while patient advocate Stephen Huff shared how targeted research enabled a treatment that extended his life following a stage 4 diagnosis.PR NewswireLung Cancer Research Foundation and AstraZeneca Announce Open Call for Research Proposals with Focus on Small Cell Lung CancerThe Lung Cancer Research Foundation (LCRF), in partnership with AstraZeneca, announced two research awards to fund investigations into small cell lung cancer (SCLC), with application deadlines in July 2026. The grants aim to advance understanding and develop new therapies for this aggressive cancer, which has limited treatment options and high resistance rates. The initiative emphasizes both scientific research and patient advocacy to improve outcomes.PR NewswireLung Cancer Research Foundation Announces Request for Proposals Open for ALK-Positive Lung Cancer Research GrantThe Lung Cancer Research Foundation announced a new two-year, $300,000 research grant focused on ALK-positive lung cancer treatment research, opening submissions on June 9, 2026. The grant aims to support translational research into overcoming drug resistance in ALK-positive non-small cell lung cancer (NSCLC). The initiative seeks to accelerate the development of next-generation therapies and clinical trials for this lung cancer subtype.PR NewswireFunding from Patients, Caregivers, Foundations and Industry Partners Fuels ALK-positive ResearchThe Lung Cancer Research Foundation announced two $300,000 two-year research awards to accelerate treatment options for ALK fusion-driven non-small cell lung cancer, funded through contributions from patients, caregivers, foundations, and industry partners including Pfizer. More than 500,000 people worldwide are living with ALK-positive NSCLC, and while third-generation ALK inhibitor lorlatinib has shown unprecedented progression-free survival results in clinical trials, resistance eventually develops in all patients, creating an urgent need for new therapeutic approaches. The foundation expects to announce the 2026 Request for Proposals in June 2026.AijournLung Cancer Research Foundation Grants Team Science Award Focused on Understanding and Treating Lung Cancers with HER2 MutationsThe Lung Cancer Research Foundation announced the first recipients of its $1.5 million LCRF|Boehringer Ingelheim Team Science Award, led by Dr. John Heymach at MD Anderson Cancer Center, to study resistance mechanisms in HER2-mutant non-small cell lung cancer. The research team will use AI, structural biology, and computational modeling to understand why current treatments stop working and develop new therapeutic approaches, with the goal of advancing findings into clinical trials. Boehringer Ingelheim co-funded the project as part of a research collaboration aimed at addressing an area of significant unmet need in oncology.PR NewswireLung Cancer Research Foundation Grants Team Science Award Focused on Understanding and Treating Lung Cancers with HER2 MutationsThe Lung Cancer Research Foundation announced the first recipients of its LCRF | Boehringer Ingelheim Team Science Award, granting $1.5 million to a research team led by Dr. John Heymach at MD Anderson Cancer Center to study resistance mechanisms in HER2-mutant non-small cell lung cancer. The four-year project will use deep mutational scanning, structural biology, computational modeling, and AI to understand why patients relapse on tyrosine kinase inhibitors and develop new therapeutic approaches. The research collaboration aims to identify candidate therapeutic targets and potentially advance findings into a phase 1 clinical trial.PR NewswireLung Cancer Research Foundation Grants Team Science Award Focused on Curing EGFR-Mutant Lung CancersThe Lung Cancer Research Foundation (LCRF) announced the first recipients of its LCRF Team Science Award focused on curing EGFR-mutant lung cancers, granting $1.5 million to research teams led by Dr. Kwok-Kin Wong and Dr. Matthew Meyerson. The research will test a novel therapeutic combination strategy to prevent drug resistance in EGFR-mutant lung cancer, with plans to launch a Phase II clinical trial for patients with high-risk EGFR-mutant non-small cell lung cancer. If successful, the approach could lead to deeper, more durable responses and improved survival outcomes for patients who currently face median survival of only around 39 months due to resistance mechanisms.PR Newswire2026 Lung Cancer Research Foundation Gala Spotlights WomenThe Lung Cancer Research Foundation (LCRF) announced its 2026 Gala, scheduled for September 23, 2026, at Cipriani 25 Broadway in Manhattan, which will honor Rose Ann Weinstein, a long-time board member, and Dr. Narjust Florez, a thoracic oncologist at Dana-Farber Cancer Institute, for their contributions to lung cancer research and advocacy. Lung cancer is the leading cause of cancer death among women in the United States, claiming as many lives annually as breast, ovarian, and cervical cancers combined, with over 600,000 women dying from the disease worldwide each year. LCRF has funded 450 research grants totaling nearly $53 million, the highest amount provided by a nonprofit dedicated to lung cancer research.PR NewswireLung Cancer Research Foundation Launches Small Cell Lung Cancer Grants in Collaboration with AstraZenecaThe Lung Cancer Research Foundation announced a new research collaboration with AstraZeneca, launching two grant awards for small cell lung cancer research totaling $750,000. The first grant, a $500,000 three-year award, will fund novel treatment strategies, while the second grant of $250,000 over two years will support patient advocacy approaches to improve patient outcomes. Requests for proposals will be announced in the coming months.MorningstarLung Cancer Research Foundation Launches Small Cell Lung Cancer Grants in Collaboration with AstraZenecaThe Lung Cancer Research Foundation announced a new research collaboration with AstraZeneca to fund two grants focused on small cell lung cancer (SCLC), a disease representing 13-15% of lung cancer cases with a five-year survival rate below 7%. The initiative includes a $500,000 three-year award for novel treatment strategies and a $250,000 two-year award for patient advocacy, totaling $750,000 in funding for 2026. Requests for proposals will be announced in the coming months.